Novus Adds 25,000+ Conjugated Antibodies to Catalog

Novus added an additional 25,000 conjugated antibodies to its catalog which now features more than 30,000 conjugated antibodies.

"With the recent release of an additional 25000+ conjugated antibodies, covering over 3,000 targets in at least 10 colors, Novus Biologicals has the most comprehensive offering of reagents to support measuring multiple targets in complex samples" said Dr. Tom Maslanik, Product Manager.

From now until September 30, 2013 researchers can save 20% on Novus Conjugated Antibodies which can be viewed at

About Novus Biologicals
Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community. All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet. By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.

Candace Sotwick, Director of Marketing
Novus Biologicals, LLC

Release Date: 
Tuesday, August 6, 2013 - 06:00